Drug Shortage Report for SANDOZ MOXIFLOXACIN

Last updated on 2022-01-18 History
Report ID 151597
Drug Identification Number 02411520
Brand name SANDOZ MOXIFLOXACIN
Common or Proper name MOXIFLOXACIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 0.5%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3ML LDP
ATC code S01AE
ATC description ANTIINFECTIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-12-20
Estimated end date 2022-01-14
Actual end date 2022-01-17
Shortage status Resolved
Updated date 2022-01-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-01-18 French Compare
v6 2022-01-18 English Compare
v5 2021-12-30 French Compare
v4 2021-12-30 English Compare
v3 2021-12-21 English Compare
v2 2021-12-20 French Compare
v1 2021-12-20 English Compare

Showing 1 to 7 of 7